September is the first month of autumn here in Norway and at Oslo Cancer Cluster we get busier with each falling leaf. We have been to Stockholm to participate in the Nordic Life Science Days and we have had prominent visitors from the USA here in the Innovation Park to enlighten us about a pioneer project run by Cancer Registry of Norway and Lawrence Livermore National Laboratory. A new and promising collaboration is also initiated between Oslo Cancer Cluster member Vaccibody and American Nektar Therapeutics.
We wish you a cosy indoor read,
The Oslo Cancer Cluster Team
Get some answers from the expert panel in this easy to read report with highlights from the oncology session that took place at the conference Nordic Life Science Days in Stockholm earlier this month.
A new combination
Norwegian personalized cancer vaccine meets American immuno-therapy drug in this collaboration between Vaccibody and American biopharmaceutical company Nektar Therapeutics.
Why did the U.S. Ambassador visit us?
This is a story about the unique American-Norwegian collaboration that combines the best health data with the most powerful computers in a pioneer project.
Live Podcast TODAY
Today, our General Manager Ketil Widerberg is a guest in a special Radium podcast about trends in health innovation. The live podcast is part of Oslo Innovation Week.
